Adding a Medicine to WHO Model List of Essential Medicines
Loading...
No Access Until
Permanent Link(s)
Collections
Other Titles
Author(s)
Abstract
Although the concept of essential medicines is not new, the processes that lead to placement of these medicines on the World Health Organization Model List of Essential Medicines are not well understood. Here, we describe the process by which we added a class of drugs, statins, to the Model List to help combat the growing global epidemic of cardiovascular disease.
Journal / Series
Volume & Issue
Description
Sponsorship
This work was supported by National Institutes of Health Medical Scientist Training Program grant GM07739 and the Paul and Daisy Soros Fellowship to S.P.K. The funders were not involved in the decision to submit the article or in its preparation.
Date Issued
2009-03
Publisher
Nature Publishing Group; Clinical Pharmacology & Therapeutics
Keywords
Essential Medicines; WHO Model List of Essential Medicines List; Statins
Location
Effective Date
Expiration Date
Sector
Employer
Union
Union Local
NAICS
Number of Workers
Committee Chair
Committee Co-Chair
Committee Member
Degree Discipline
Degree Name
Degree Level
Related Version
Related DOI
Related To
Related Part
Based on Related Item
Has Other Format(s)
Part of Related Item
Related To
Related Publication(s)
Link(s) to Related Publication(s)
References
Link(s) to Reference(s)
Previously Published As
Clin. Pharmacol. Ther. 2009. March; 85(3): 237-9
Government Document
ISBN
ISMN
ISSN
Other Identifiers
Rights
Rights URI
Types
article